A life science recruiter's blog on placing R&D professionals.

  • Pfizer and AstraZeneca: More Loss of Jobs to Come

    Well, I finally have something to write about again. Lately, I just haven’t had much to say here. But the latest news about Pfizer trying to buy AstraZeneca for $100 billion just sickens me. After 20 years of recruiting exclusively for pharmaceutical and biotechnology companies, I have seen this merger business enough to know it […]

    Read more.
  • Ellen Clark, President of Clark Executive Search, in Xconomy Article

    A month or so ago, Luke Timmerman ( @ldtimmerman ) , National Biotech Editor for Xconomy, interviewed me ( Ellen Clark) about my reaction to a NY Times piece which talked about the hoops candidates have to go through to get hired and the time it takes. I had a post mostly completed at the […]

    Read more.
  • Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves

    This review is on the book “ Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves” by George Church and Ed Regis. George Church, PhD is a fascinating Harvard scientist, who I have met at several GET Conferences  and is often mentioned when anyone talks about genomics. His credentials are numerous, but one highlight is that he is the […]

    Read more.
  • A Hot Biotech Company, Moderna Therapeutics

    I’m writing to introduce you to a hot biotech in Cambridge, Massachusetts that just so happens to also be a client of Clark Executive Search. If you are a follower of FierceBiotech or twitter I am sure you will have heard of Moderna Therapeutics. But if not, here is a bit about them and the […]

    Read more.